Does once-weekly tirzepatide reduce body weight in adults with obesity?

In adults with obesity, once-weekly tirzepatide reduced body weight substantially more than placebo over 72 weeks, by up to about 21%.

Randomized trial · NEJM 2022

Reference: Jastreboff AM, Aronne LJ, Ahmad NN. N Engl J Med. 2022; PMID:35658024

Chapters

0:00 Intro

0:38 The trial

3:12 My take

3:48 Outro

Read the structured trial summary at https://hormoneinsight.com/

AI-generated narration. This podcast is intended for healthcare professionals and is for educational purposes only; it is not medical advice. Any views expressed are the presenter's own and do not necessarily reflect the views of any institution he works with.

Explore Hormone Insight:

Website: https://hormoneinsight.com/

Apple App Store: https://apps.apple.com/sa/app/hormone-insight/id6749515856

Google Play: https://play.google.com/store/apps/details?id=com.fahadwali78.hormoneinsightmobile&hl=en